The Exclusion of the Elderly and Women From Clinical Trials in Acute Myocardial Infarction

JAMA: The Journal of the American Medical Association

Volumn 268, Issue 11, 1992, Pages 1417-1422

  Gurwitz, Jerry H ^a,b   Col, Nananda F ^c   Avorn, Jerry ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b RESEARCH AND TRAINING INSTITUTE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; FIBRINOLYTIC AGENT; NITRATE; VASODILATOR AGENT;

ACUTE HEART INFARCTION; AGED; AGING; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH; BIOMEDICAL RESEARCH; CLINICAL APPROACH/SOURCE; EMPIRICAL APPROACH; FEMALES; RESEARCH SUBJECTS; SELECTION OF SUBJECTS; SURVEY; THERAPEUTIC RESEARCH;

AGE FACTORS; AGED; BIAS (EPIDEMIOLOGY); FEMALE; HUMAN; LINEAR MODELS; MEDLINE; MIDDLE AGE; MORBIDITY; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOLYTIC THERAPY; WOMEN;

EID: 0026782559     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1992.03490110055029     Document Type: Article

References (43)

1. Graves EJ. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1989. Vital Health Stat 13. 1991;No. 108.
2. Health statistics on older persons, United States, 1986. Vital Health Stat 3. 1987; No. 25.
3. Kapantais G, Powell-Griner E. Characteristics of Persons Dying of Disease of Heart: Preliminary Data from the 1986 National Mortality Followback Survey. Hyattsville, Md: National Center for Health Statistics; 1989. Advancedata from Vital and Health Statistics No. 172.
4. Goldberg RJ, Gore JM, Gurwitz JH, et al. The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J. 1989;117:543-549.
5. Smith SC, Gilpin E, Ahnve S, et al. Outlook for acute myocardial infarction in the very elderly compared with that in patients 65 to 75 years. J Am Coll Cardiol. 1990;16:784-792.
6. Montague TJ, Ikuta RM, Wong RY, Bay KS, Teo KK, Davies NJ. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989). Am J Cardiol. 1991;68: 843-847.
7. Jecker NS. Age-based rationing and women. JAMA. 1991;266:3012-3015.
8. Statistical Abstract of the United States: 1990. 110th ed. Washington, DC: US Bureau of the Census; 1990.
9. Warnes CA, Roberts WC. Comparison at necropsy by age group of amount and distribution of narrowing by atherosclerotic plaque in 2995 5-mm-long segments of 240 major coronary arteries in 60 men aged 31 to 70 years with sudden coronary death. Am Heart J. 1984;108:431-435.
10. Fisher LD, Maynard C, Rademaker AW, Alderman EL, Mock M. Age variation in the association between angiographic coronary disease and angina from the Coronary Artery Surgery Study (CASS). Int J Cardiol. 1989;24:317-326.
11. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med. 1992;326:242-250.
12. Lakatta EG, Yin FCP. Myocardial aging: functional alterations and related cellular mechanisms. Am J Physiol. 1982;242:H927-H941.
13. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med. 1989;321:303-309.
14. Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the elderly? JAMA. 1991;265:1720-1723.
15. Cotton P. Is there still too much extrapolation from data on middle-aged white men? JAMA. 1990; 263:1049-1050.
16. Adolph RJ. The elderly, the very elderly and traditional practice patterns. J Am Coll Cardiol. 1990;16:793-794.
17. Wilhelmsen L. Trials in coronary heart disease and hypertension with special reference to the elderly. Eur Heart J. 1988;9:207-214.
18. Yusuf S, Furberg CD. Are we biased in our approach to treating elderly patients with heart disease? Am J Cardiol. 1991;68:954-956.
19. Douglas PS. Gender, cardiology, and optimal medical care. Circulation. 1986;74:917-919.
20. Levey BA. Bridging the gender gap in research. Clin Pharmacol Ther. 1991;50:641-646.
21. Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of randomised trials. Lancet. 1988;1:1088-1092.
22. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from randomized, controlled trials. JAMA. 1988;260:1910-1916.
23. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease, I: treatments following myocardial infarction. JAMA. 1988;260:2088-2093.
24. SAS Institute. SAS Release 6.04. Cary, NC: SAS Institute Inc; 1987.
25. Kleinbaum DG, Kupper KL, Muller KE. Applied Regression Analysis and Other Multivariable Methods. Boston, Mass: PWS-Kent Publishing Company; 1988.
26. Yusuf S, Held P, Yeo KK. Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. Stat Med. 1990;9:73-86.
27. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet. 1990;336:65-71.
28. Wilhelmsson C, Vedin JA, Wilhelmsen L, Tibblin G, Werko L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet. 1974;2:1157-1160.
29. Evemy KL, Pentecost BL. Intravenous and oral practolol in the acute stages of myocardial infarction. Eur J Cardiol. 1978;2:391-398.
30. Dunn HM, McComb JM, Kinney CD, et al. Prophylactic lidocaine in the early phase of suspected myocardial infarction. Am Heart J. 1985;110:353-362.
31. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991;114:956-966.
32. National Center for Health Statistics. Vital Statistics of the United States, 1988. Washington DC: Public Health Service; 1991:2(pt A).
33. Fulton JP, Katz S, Jack SS, Hendershot GE. Physical functioning of the aged: United States, 1984. Vital Health Stat 10. 1989;No. 167.
34. Weaver WD, Litwin PE, Martin JS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol. 1991;18:657-662.
35. Rich MW, Bosner MS, Chung MK, Shen J, McKenzie JP. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? Am J Med. 1992;92:7-13.
36. Manolio TA, Furberg CD. Age as a predictor of outcome: what role does it play? Am J Med. 1992; 92:1-6.
37. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;1:1349-1354.
38. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265: 3255-3264.
39. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338: 1281-1285.
40. Ross AM. The TTOPP study: lessons from an aborted trial. J Myocardial Ischemia. 1990;2:65-69.
41. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-401.
42. ISIS-2 (Second Collaborative Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1987;1:349-360.
43. Guideline for the Study of Drugs Likely to be Used in the Elderly. Rockville, Md: Center for Drug Evaluation and Research, Food and Drug Administration; 1989.